Annual Global Discovery to Development Innovation Forum Speakers
VP Novel Target Biology and Genomics
Alun is currently VP Novel Target Biology and Genomics at C4X Discovery. He has over 35 years experience in pharmaceutical R&D, including drug discovery and genetics research. After 20 years experience in GSK, Alun founded small company to develop the novel approach to analysis of genetic data. In 2016, this company was acquired by C4X Discovery, adding novel target identification to C4X’s existing Conformetrix methodology for small molecule design.